The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
December 1978 (Volume 56)
Quarterly Article
Anne-Marie Foltz
Jennifer L. Kelsey
Nov 5, 2024
Oct 30, 2024
Oct 23, 2024
Back to The Milbank Quarterly
The annual Pap test became a recommended standard for American women without ever having been subjected to controlled trials to estimate its efficacy and effectiveness. After more than 30 years of routine use, the Pap test fails to meet most of the generally accepted criteria for a mass screening program. The policy persists, however, because the nation’s ideology supports the maximum utilization of new technologies; and special interest groups have promoted the test as the major weapon in the “War on Cancer.” With some exceptions, this is a questionable allocation of public and private health resources.
Author(s): Anne-Marie Foltz; Jennifer L. Kelsey
Download the Article
Read on JSTOR
Volume 56, Issue 4 (pages 426–462) Published in 1978
